Drug development service is the proceeding of a new drug. Molecular manipulation, molecular designing, random screening, drug metabolites, and serendipity are the most common methods for drug discovery. Drug developmentreduces the costs and schedules for drug discovery. The methodof drug discovery is used in biotechnology, pharmacology, and medicine to discover and design new medications.Furthermore, drug development service is used to discover and formulate for the pharmaceutical, biotechnology and biopharmaceutical industries. This process involves various steps such as identification of applicants, synthesis, characterization, screening, and assays for therapeutic efficacy.Pharmaceutical drug development services are provided by CROs to pharmaceutical companies. The services include lead identification, drug discovery assistance, project management, clinical trials, and help in the development of drugs. The momentum spent on this market is accredited to the investments in developing drugs that can combat various diseases such as MS, HIV, and cancer.
Drug development servicesare mostly used in paternity testing, forensics, and anthropology with DNA analysis, and disaster victim identification is an important tool for this sector.
COVID-19 scenario analysis:
- Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs, such as hydroxychloroquine, have witnessed a dramatic surge in demand for the management of COVID-19.
- Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs as many developed countries are short of these drugs. The pharmaceutical and biotechnology industries are expected to witness a significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19.
- Attributed to such factors, COVID-19 is expected to have a significant impact on the market.
Top impacting factors: Market scenario analysis, trends, drivers and impact analysis
Augmented demand and supply for medicines, technological upgrades, and upswing in the adoption of innovative techniques for discoveriesand increase in the number of patents’ expiry escalate the market growth globally. Increase in R&D activities, healthcare sector developments, rise in awareness among population about chronic diseases, rise in number of contract development, and manufacturers that stimulating drug discovery and rapidly build up the pharmaceutical industry are factors that encourage the growth of the drug development services market. Developing countries are expected to be at the center of this market.
On the other hand, high investment required as capital but low-profit marginsand strict regulations by Food and Drug Administration hamper the growth of the drug development services market. Moreover, healthcare system challenges in underdeveloped and developing countries impede the growth of the drug discovery services market.
New product launches to boost the market
InApril 2019, Charles River and CHDI Foundation Inc. collaborated on drug discovery and development. This collaboration is a five-year extension while they started working together in 2005 for Huntington’s disease.On10 September 2019, Laboratory Corporation (LabCorp) of America Holdings’s inaugurated the Covance Drug Development segment for R&D center in Shanghai, which is the largest in the Asia-Pacific region.Thermo Fisher Scientific introduced KaryoSat assays in stem cell research to accelerate research.On April 9, 2019, Eurofins Discovery announced a new drug discovery service,DiscoveryOne Integrated Drug Services.
Key benefits of the report:
- This study presents the analytical depiction of the drug development services market along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the drug development services market share.
- The current market is quantitatively analyzed to highlight the drug development services market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed analysis based on competitive intensity and how the competition will take shape in coming years.
Questions answered in the drug development services market research report:
- Which are the leading market players active in the market?
- What are the current trends that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities of the market?
- What are the projections for the future that would help in taking further strategic steps?
Drug Development Services Market Report Highlights
| Aspects | Details |
 By Therapeutic Area |
|
 By Process |
|
 By Type |
|
 By Region |
|
 Key Market Players | Shanghai Medicilon, Albany Molecular Research Inc., Eurofins Scientific, Aurigene Discovery Technologies Ltd., WuXi AppTec, Thermo Fisher Scientific, Inc., Selvita S. A., Evotec SE, TCG Lifesciences Pvt. Ltd., Biotech Corporation |
Loading Table Of Content...
